Topic
SpaceX Research
Current institutional research highlights a market environment that prioritizes private equity and large-scale technological infrastructure, both of which are central to the SpaceX narrative. While Goldman Sachs reports aggressive selling within the Industrials sector, there is a persistent institutional appetite for private markets as diversifiers that offer higher returns and lower volatility than traditional public indices. This focus on private assets is increasingly relevant as BlackRock emphasizes a 'speed and scarcity' theme, particularly regarding the projected $1 trillion annual AI infrastructure buildout. Despite potential headwinds from hawkish Federal Reserve policies and high institutional leverage reaching five-year peaks, there remains a tactical preference for U.S. equities and technology beneficiaries. Additionally, the development of liquid private equity investment vehicles is bridging the gap for retail access to historically illiquid segments of the market. Consequently, the research suggests that while the broader industrial sector faces selling pressure, capital continues to flow toward high-growth, private-market leaders that define the next generation of technological expansion.
4281 reports available
All reports
Page 72 of 179
EU Utilities and Infrastructure Daily Wire
J.P. Morgan · Jun 9, 2026
Credit Calls
J.P. Morgan · Jun 9, 2026
Grupo Aeroportuario Del Sureste May Traffic Update
Goldman Sachs · Jun 9, 2026
Research Morning Line Express
Natsos · Jun 9, 2026
Early Morning Reid
Deutsche Bank · Jun 9, 2026
Italian Banks First Thoughts On M&A Scenarios
Barclays · Jun 9, 2026
Inside Commodities
London Stock Exchange Group · Jun 9, 2026
Flows & Liquidity
J.P. Morgan · Jun 9, 2026
US Daily May CPI Preview
Goldman Sachs · Jun 9, 2026
Fixed Income Weekly Update
Piper Sandler · Jun 9, 2026
Trading Catalysts
Bank of America · Jun 8, 2026
The Global Point
Citi · Jun 8, 2026
US Biopharmaceuticals: Is It Time To Reassess Biopharma
Bank of America · Jun 8, 2026
Asia FX Talk
MUFG · Jun 8, 2026
The Obesity Evolution: Refining Our Global Anti-Obesity Medication Market Model
Goldman Sachs · Jun 8, 2026
US Weekly Kickstart Evaluating Exuberance
Goldman Sachs · Jun 8, 2026
Europe Equity Research Today's Morning Meeting
J.P. Morgan · Jun 8, 2026
The Point For Europe
Citi · Jun 8, 2026
Market Rhythm Focus
EFG · Jun 8, 2026
Technical Views Equity Indices
Pictet · Jun 8, 2026
SpaceX IPO Countdown to Potential Index Inclusion
UBS · Jun 8, 2026
How Will The Iran Conflict Impact Commodities
UBS · Jun 8, 2026
Flow Exo Menu
Goldman Sachs · Jun 8, 2026
Middle East Daily
MUFG · Jun 8, 2026